Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gough

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Regulatory Toxicology and Pharmacology : RTP|August 31, 2002
Antagonism--no synergism--in pairwise tests of carcinogens in ratsMichael Gough
The Journal of Clinical Investigation|September 15, 2022
Moving beyond the T cell synapse for combination neoadjuvant immunotherapy in head and neck cancerR Bryan Bell, Michael Gough, Marka Crittenden, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2004
MIP-3alpha transfection into a rodent tumor cell line increases intratumoral dendritic cell infiltration but enhances (facilitates) tumor growth and decreases immunogenicityBernard Bonnotte, Marka Crittenden, Nicolas Larmonier, et al.
Journal of the American Geriatrics Society|December 2, 2004
Indicators of recurrent hospitalization for pneumonia in the elderlyAli A El Solh, Thomas Brewer, Mifue Okada, et al.
Critical Reviews in Toxicology|June 23, 2012
Re-analysis of Ranch Hand study supports reverse causation hypothesis between dioxin and diabetesBrent D Kerger, Paul K Scott, Marian Pavuk, et al.
The Journal of Surgical Research|June 12, 2017
"Take-home" box trainers are an effective alternative to virtual reality simulatorsMarina Yiasemidou, Jonathan de Siqueira, James Tomlinson, et al.
Cancer Research|September 23, 2003
Expression of inflammatory chemokines combined with local tumor destruction enhances tumor regression and long-term immunityMarka Crittenden, Michael Gough, Kevin Harrington, et al.
Cancer Research|May 3, 2003
Intradermal injection, as opposed to subcutaneous injection, enhances immunogenicity and suppresses tumorigenicity of tumor cellsBernard Bonnotte, Michael Gough, Vy Phan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
Gene therapy to manipulate effector T cell trafficking to tumors for immunotherapyMichael Gough, Marka Crittenden, Uma Thanarajasingam, et al.
Blood|July 17, 2009
Safety and immunologic effects of IL-15 administration in nonhuman primatesCarolina Berger, Michael Berger, Robert C Hackman, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Regulatory Toxicology and Pharmacology : RTP|August 31, 2002
Antagonism--no synergism--in pairwise tests of carcinogens in ratsMichael Gough
The Journal of Clinical Investigation|September 15, 2022
Moving beyond the T cell synapse for combination neoadjuvant immunotherapy in head and neck cancerR Bryan Bell, Michael Gough, Marka Crittenden, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2004
MIP-3alpha transfection into a rodent tumor cell line increases intratumoral dendritic cell infiltration but enhances (facilitates) tumor growth and decreases immunogenicityBernard Bonnotte, Marka Crittenden, Nicolas Larmonier, et al.
Journal of the American Geriatrics Society|December 2, 2004
Indicators of recurrent hospitalization for pneumonia in the elderlyAli A El Solh, Thomas Brewer, Mifue Okada, et al.
Critical Reviews in Toxicology|June 23, 2012
Re-analysis of Ranch Hand study supports reverse causation hypothesis between dioxin and diabetesBrent D Kerger, Paul K Scott, Marian Pavuk, et al.
The Journal of Surgical Research|June 12, 2017
"Take-home" box trainers are an effective alternative to virtual reality simulatorsMarina Yiasemidou, Jonathan de Siqueira, James Tomlinson, et al.
Cancer Research|September 23, 2003
Expression of inflammatory chemokines combined with local tumor destruction enhances tumor regression and long-term immunityMarka Crittenden, Michael Gough, Kevin Harrington, et al.
Cancer Research|May 3, 2003
Intradermal injection, as opposed to subcutaneous injection, enhances immunogenicity and suppresses tumorigenicity of tumor cellsBernard Bonnotte, Michael Gough, Vy Phan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
Gene therapy to manipulate effector T cell trafficking to tumors for immunotherapyMichael Gough, Marka Crittenden, Uma Thanarajasingam, et al.
Blood|July 17, 2009
Safety and immunologic effects of IL-15 administration in nonhuman primatesCarolina Berger, Michael Berger, Robert C Hackman, et al.
Pageof 4